Martina Smolic

University of OsijekCroatia

Dr. Martina Smolić is an assistant professor of Pharmacology, a program director of Postgraduate Doctoral Study of Biomedicine and Health, and also the head of the Department of Pharmacology at the University of Osijek, Faculty of Medicine. During her postdoctoral training at the University of Connecticut, she investigated the development of prospective agents for the treatment of HCV infection. Her research interests include targeted delivery to hepatocytes, mechanisms of hepatotoxicity, and mineral metabolism disorders. She has received awards from the German Research Foundation, Croatian Ministry of Science, International Society for Applied Biological Sciences, and Croatian Science Foundation and she was elected to “20 best research fellows in Croatia.” She actively publishes original research work and serves as a member of the editorial board of the Journal of Clinical and Translational Hepatology.

1books edited

6chapters authored

Latest work with IntechOpen by Martina Smolic

In the past few years, remarkable progress has been made in our understanding of HCV biology, pathogenesis of infection, and structure-function relationships. This has led to quantum advances in clinical efficacy and tolerability. Yet, in spite of this amazing progress, there remain obstacles to widespread successful treatment. These issues include biological failures even with direct-acting agents, lack of options for individual with organ failures, drug-drug interactions, access to medications either due to lack of availability or affordability, and psychiatric and social issues. These problems are likely to remain in the future. Therefore, this book has been created by distinguished faculties from around the world to address the progress in our understanding of HCV infection and to review new treatment options, limitations, and accessibility of new therapeutic options.

Go to the book